Craig M Pratt

Summary

Affiliation: The Methodist Hospital
Country: USA

Publications

  1. doi request reprint Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study
    Craig M Pratt
    Methodist DeBakey Heart and Vascular Center, 6565 Fannin Street, F1001, Houston, TX 77030, USA
    Am Heart J 158:163-169.e1-3. 2009
  2. doi request reprint Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation
    Craig M Pratt
    Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Methodist Research Institute, Houston, Texas, USA
    Am J Cardiol 106:1277-83. 2010
  3. ncbi request reprint Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database
    Craig M Pratt
    Department of Cardiology, Methodist DeBakey Heart Center, Houston, Texas 77030, USA
    J Am Coll Cardiol 48:471-7. 2006
  4. ncbi request reprint Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator
    Craig M Pratt
    The Methodist DeBakey Heart Center and the Section of Cardiology, Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
    Am J Cardiol 95:274-6. 2005
  5. doi request reprint The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk
    Su Min Chang
    Methodist DeBakey Heart and Vascular Center and The Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas, USA
    J Am Coll Cardiol 54:1872-82. 2009
  6. ncbi request reprint The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial
    Craig M Pratt
    The Methodist DeBakey Heart Center and Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Am Coll Cardiol 43:1211-6. 2004
  7. doi request reprint Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
    Guillermo Torre-Amione
    Heart Transplant Program, Methodist DeBakey Heart Center, Methodist Hospital, Houston, TX 77030, USA
    Lancet 371:228-36. 2008
  8. doi request reprint Coronary artery calcium scoring in the emergency department: identifying which patients with chest pain can be safely discharged home
    Faisal Nabi
    Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA
    Ann Emerg Med 56:220-9. 2010

Detail Information

Publications8

  1. doi request reprint Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study
    Craig M Pratt
    Methodist DeBakey Heart and Vascular Center, 6565 Fannin Street, F1001, Houston, TX 77030, USA
    Am Heart J 158:163-169.e1-3. 2009
    ..This study is designed to further assess the effect of prescription omega-3 ethyl esters (P-OM3) in the prevention of recurrent AF in patients with AF without (significant) structural heart disease...
  2. doi request reprint Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation
    Craig M Pratt
    Department of Cardiology, Methodist DeBakey Heart and Vascular Center, Methodist Research Institute, Houston, Texas, USA
    Am J Cardiol 106:1277-83. 2010
    ..In conclusion, vernakalant demonstrated a rapid and high rate of conversion for short-duration AF and was well tolerated...
  3. ncbi request reprint Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database
    Craig M Pratt
    Department of Cardiology, Methodist DeBakey Heart Center, Houston, Texas 77030, USA
    J Am Coll Cardiol 48:471-7. 2006
    ..The purpose of this study was to assess the incidence, temporal characteristics, and risk factors associated with azimilide-associated torsades de pointes (TdP) ventricular tachycardia...
  4. ncbi request reprint Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator
    Craig M Pratt
    The Methodist DeBakey Heart Center and the Section of Cardiology, Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston, TX 77030, USA
    Am J Cardiol 95:274-6. 2005
    ..The primary efficacy end points are time to all-cause shocks and time to all-cause shocks plus symptomatic ventricular arrhythmic events triggering antitachycardia pacing measured from randomization...
  5. doi request reprint The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk
    Su Min Chang
    Methodist DeBakey Heart and Vascular Center and The Methodist Hospital Research Institute, The Methodist Hospital, Houston, Texas, USA
    J Am Coll Cardiol 54:1872-82. 2009
    ..This study sought to examine the relationship between coronary artery calcium score (CACS) and single-photon emission computed tomography (SPECT) results for predicting the short- and long-term risk of cardiac events...
  6. ncbi request reprint The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction: results from the Azimilide Postinfarct Survival Evaluation (ALIVE) trial
    Craig M Pratt
    The Methodist DeBakey Heart Center and Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas 77030, USA
    J Am Coll Cardiol 43:1211-6. 2004
    ....
  7. doi request reprint Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial
    Guillermo Torre-Amione
    Heart Transplant Program, Methodist DeBakey Heart Center, Methodist Hospital, Houston, TX 77030, USA
    Lancet 371:228-36. 2008
    ..Evidence suggests that inflammatory mediators contribute to development and progression of chronic heart failure. We therefore tested the hypothesis that immunomodulation might counteract this pathophysiological mechanism in patients...
  8. doi request reprint Coronary artery calcium scoring in the emergency department: identifying which patients with chest pain can be safely discharged home
    Faisal Nabi
    Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA
    Ann Emerg Med 56:220-9. 2010
    ..Our objective is to evaluate whether a CACS of zero will identify chest pain patients who can be safely discharged home, without need for further cardiac testing...